Table 1. NAG, microalbumin and other laboratory variables in the group of patients treated with Ketoprofen only, and in the group with combined use of Ketoprofen and Methotrexate.
| KETOPROFEN GROUP No 35 | KETOPROFEN+METHOTREXAT GROUP No 35 | |||||
|
NAG + >1.18 (U/mmol/crea) value (M ± SD) normal range (%) / elevated values (%) |
MICROALBUMINURIA + >20 (mg/L) value (M ± SD) normal range (%) / elevated values (%) |
GFR |
NAG + >1.18 (U/mmol/crea) value (M ± SD) normal range (%) / elevated values (%) |
MICROALBUMINURIA + >20 (mg/L) value (M ± SD) normal range (%) / elevated values (%) |
GFR | |
|
0 spot |
1.13±0.54 22 (63%) / 13(37%) |
17.91±11.17 30 (86%)/ 5 (14%) |
99.5±22.5 |
0.93±0.48 25 (71%)/ 10 (29%) |
16.35±7.41 30 (86%)/ 5 (14%) |
95.9±32.6 |
|
4th week |
1.27±0.48 17 (49%) / 18 (51%) |
19.55±11.46 28 (80%) / 7(20%) |
99.9±24.1 |
1.27±0.47 18 (51% ) / 17 (49%) |
18.21±7.63 26 (74%) / 9 (26%) |
97.1±39.4 |
|
8th week |
1.49±0.67 12 (34%) / 23 (66%) |
18.91±13.03 30 (86%)/ 5 (14%) |
102.9±30.1 |
1.99±1.00 4 (11%)/ 31 (89%) |
20.50±9.69 25 (71%)/ 10 (29%) |
98.8±36.1 |
|
16th week |
1.65±0.74 8 (23%) / 27 (77%) |
18.08±11.68 32 (91%)/ 3 (9%) |
101.2±25.5 |
1.94±1.02 10 (29%)/ 25 (71%) |
17.02±5.64 29 (83%)/ 6 (17%) |
95.9±32.6 |
|
24th week |
1.36±0.57 15 (43%) / 20 (57%) |
18.14±12.65 32 (91%)/ 3 (9%) |
98.8±22.3 |
1.36±0.83 21 (60%)/ 14 (40%) |
14.74±8.56 32 (91%)/ 3 (9%) |
98.9±44.3 |